4 research outputs found
Approaches to Using e- and m-Business Components in Business
This paper discusses using e- and m-business components in supporting and enhancing existing businesses and in creating new business innovations. A framework illustrating two different approaches companies have to adoption of e- and m-business components is proposed. Three cases of how Finnish companies have, in an innovative way, used e- and m-business components to support, to enhance, and to launch businesses are presented. Based on the illustrative framework and the cases, some rules of thumb for using e- and m-business components in business are proposed. The aim of this paper is to offer managers helpful insights for planning e- and m-business component investments.e-Business; m-Business; Business Models; Case Studies
Learning Based High-Level Decision Making for Abortable Overtaking in Autonomous Vehicles
Autonomous vehicles are a growing technology that aims to enhance safety,
accessibility, efficiency, and convenience through autonomous maneuvers ranging
from lane change to overtaking. Overtaking is one of the most challenging
maneuvers for autonomous vehicles, and current techniques for autonomous
overtaking are limited to simple situations. This paper studies how to increase
safety in autonomous overtaking by allowing the maneuver to be aborted. We
propose a decision-making process based on a deep Q-Network to determine if and
when the overtaking maneuver needs to be aborted. The proposed algorithm is
empirically evaluated in simulation with varying traffic situations, indicating
that the proposed method improves safety during overtaking maneuvers.
Furthermore, the approach is demonstrated in real-world experiments using the
autonomous shuttle iseAuto.Comment: 11 pages, 16 figures. This work has been submitted to the IEEE for
possible publication. Copyright may be transferred without notice, after
which this version may no longer be accessibl
Approaches to Using e- and m-Business Components in Business
This paper discusses using e- and m-business components in supporting and enhancing existing
businesses and in creating new business innovations. A framework illustrating two different
approaches companies have to adoption of e- and m-business components is proposed. Three
cases of how Finnish companies have, in an innovative way, used e- and m-business
components to support, to enhance, and to launch businesses are presented. Based on the
illustrative framework and the cases, some rules of thumb for using e- and m-business
components in business are proposed. The aim of this paper is to offer managers helpful insights
for planning e- and m-business component investments
Symptoms and diagnostic delays in bladder cancer with high risk of recurrence : results from a prospective FinnBladder 9 trial
Purpose To investigate the symptoms and delays in the clinical pathway of bladder cancer (BC). Methods This is a substudy of a prospective, randomized, multicenter phase III study (FinnBladder 9, NCT01675219) where the efficacy of photodynamic diagnosis and 6 weekly optimized mitomycin C instillations are studied in pTa bladder cancer with high risk for recurrence. The data of presenting symptoms and critical time points were prospectively collected, and the effect of factors on delays was analyzed. Results At the time of analysis, 245 patients were randomized. Analysis included 131 patients with primary bladder cancer and their complete data. Sixty-nine percent had smoking history and 67% presented with macroscopic hematuria. Median patient delay (from symptoms to health-care contact) was 7 days. The median general practice delay (from health-care contact to urology referral) was 8 days. Median time from urology referral to cystoscopy was 23 days and from cystoscopy to TUR-BT 21 days. Total time used in the clinical pathway (from symptom to TUR-BT) was 78 days. Current and former smokers had non-significantly shorter patient-related and general practice delays compared to never smokers. TUR-BT delay was significantly shorter in patients with malignant cytology (16 days) compared to patients with benign cytology (21 days, p = 0.03). Conclusions Patient-derived delay was short and most of the delay occurred in the referral centers. The majority had macroscopic hematuria as the initial symptom. Surprisingly, current and past smokers were more prone to contact the health-care system compared to never smokers.Peer reviewe